NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
Press release Nanoform Finland Plc August 15, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform COLLABORATES WITH TAKEDA on THEIR PLASMA-DERIVED Therapy Development Helsinki, Finland – August 15, 2024 - Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biopharmaceutical company headquartered in Japan, to develop innovative plasma-derived therapy formulations for